Loading...
Loading...

by Emcure Pharmaceuticals Ltd· 10S
SKU: 414245
You save ₹120 on this order
Inclusive of all taxes
MYPLAT 360MG TABLET contains Mycophenolate mofetil which belongs to the group of
medicines called Immunosuppressants. It is used to manage your body rejecting a
transplanted organ (such as kidney, heart, and liver). It is also given with
other medications such as corticosteroids and ciclosporin.
Your doctor will perform some regular blood tests to monitor any changes in your
body. MYPLAT 360MG TABLET may increases the risk of skin cancer. Limit your
exposure to sunlight and ultraviolet light by covering the exposed areas of skin
as much as possible and by applying sunscreen with a high protective factor.
MYPLAT 360MG TABLET can cause birth defects and miscarriage, hence it is
strictly not recommended for use in pregnant women and breastfeeding women.
MYPLAT 360MG TABLET is not recommended for use in children under 2 years of age.
Contact your doctor before taking.
MYPLAT 360MG TABLET should be used with caution in elderly patients aged 65
years or above. Contact your doctor before taking MYPLAT 360MG TABLET.
The most common side effects of taking MYPLAT 360MG TABLET are nausea, vomiting,
diarrhea, stomach pain, headache, high blood pressure, and low number of white
blood cells. Contact your doctor if the above side effects worsen.
MYPLAT 360MG TABLET belongs to immunosuppressants which reduces the action of
the body's own defense system (the immune system) and manages rejection of the
transplanted organ.
Take MYPLAT 360MG TABLET as advised by your physician. Swallow the medicines
with a glass of water. Do not crush or chew the medicine. Your dosage will vary
depending on the type of transplant you received. Do not stop the medicine
suddenly without the concern of your doctor.
Stop taking MYPLAT 360MG TABLET and contact your doctor immediately if you
experience any of the following side effects:
Diarrhoea:
Drink plenty of water and fruit juice to keep yourself hydrated. Contact your
doctor if the diarrhea did not improve.
Headache:
Rest and relax. Drink plenty of fluids such as water and electrolytes. Apply a
pain-relieving balm on the head if necessary. Do not consume alcohol. Contact
your doctor if the headache did not improve.
Nausea and Vomiting:
Take the medicine, with or just after a meal. Stick to simple meals. Avoid
eating oily or spicy food. Contact your doctor if nausea and vomiting did not
improve.
Dizziness:
Try to rest and relax. Get enough sleep. Avoid driving or operate any machines
while you are feeling dizzy. Do not drink alcohol, as it can aggravate your
dizziness. Contact your doctor if the dizziness did not improve.
Stomach pain:
Try to rest and relax. Eat small meals but take frequently. Keep a heat pad on
your stomach. Contact your doctor if the stomach pain did not improve.
!### PREGNANCY
MYPLAT 360MG TABLET is not recommended for use in pregnant women. Inform your
doctor if you are planning to have a child before taking this medicine. Contact
your doctor before taking MYPLAT 360MG TABLET.
!### BREASTFEEDING
MYPLAT 360MG TABLET is generally not recommended for use in breastfeeding women,
hence small amounts of the medicine can pass into the mother’s milk. Contact
your doctor before taking MYPLAT 360MG TABLET.
!### DRIVING AND USING MACHINES
Do not drive or operate any machines if you feel drowsiness, somnolence,
dizziness, tremor, low blood pressure, numb or confusion after taking MYPLAT
360MG TABLET.
!### KIDNEY
MYPLAT 360MG TABLET should be used with caution in patients with kidney
diseases. Contact your doctor before taking MYPLAT 360MG TABLET.
!### LIVER
MYPLAT 360MG TABLET should be used with caution in patients with liver diseases.
Contact your doctor before taking MYPLAT 360MG TABLET.
!### ALLERGY
Do not take MYPLAT 360MG TABLET if you are allergic (hypersensitive) to
Mycophenolate mofetil, or to some sugars such as lactose, galactose, or glucose
or to other ingredients of this medicine.
!### LUNGS
MYPLAT 360MG TABLET should be used with caution in patients with lung diseases.
Contact your doctor before taking MYPLAT 360MG TABLET.
!### HEART DISEASE
MYPLAT 360MG TABLET should be used with caution in patients with heart diseases.
Contact your doctor before taking MYPLAT 360MG TABLET.
MYPLAT 360MG TABLET is not recommended for use if you:
Before taking MYPLAT 360MG TABLET, inform your doctor if you:
Use in pediatrics:
MYPLAT 360MG TABLET is not recommended for use in children under the age of 2,
because there is limited information on its safety and effectiveness. Contact
your doctor before taking MYPLAT 360MG TABLET.
Use in geriatrics:
MYPLAT 360MG TABLET should be used with caution in elderly patients aged 65
years or above. Contact your doctor before taking MYPLAT 360MG TABLET.
A. Drug-Drug interactions:
Before taking MYPLAT 360MG TABLET, inform your doctor if you are taking any of
the following medicine:
Overdosage:
If you or anyone else accidentally takes too much of MYPLAT 360MG TABLET,
consult your doctor immediately or visit the nearby hospital. Symptoms include
nausea, vomiting, diarrhea, and neutropenia.
| Drug | : | Mycophenolate mofetil |
| Pharmacological Category | : | Immunosuppressants |
| Therapeutic Indication | : | Prevents your body from rejecting a transplanted organ |
| Dosage Forms | : | Tablet, Capsule, Suspension, Oral suspension |
What is MYPLAT 360MG TABLET used for?
MYPLAT 360MG TABLET is used to manage your body from rejecting an organ
transplant (such as kidney, heart, and liver). Contact your doctor before taking
MYPLAT 360MG TABLET.
Can I use MYPLAT 360MG TABLET in pregnancy?
No. MYPLAT 360MG TABLET is strictly not recommended for use in pregnant women
unless considered necessary. Contact your doctor before taking MYPLAT 360MG
TABLET.
Is MYPLAT 360MG TABLET safe?
Yes, MYPLAT 360MG TABLET is safe and well tolerated. Contact your doctor before
taking.
Can I use MYPLAT 360MG TABLET in children?
No, MYPLAT 360MG TABLET is not recommended for use in children under the age of
2, because there is limited information on its safety and effectiveness for
them. Contact your doctor before taking.
How MYPLAT 360MG TABLET work?
MYPLAT 360MG TABLET belongs to immunosuppressants which reduces the action of
the body's own defense system (the immune system) and manages rejection of the
transplanted organ.
Can I use MYPLAT 360MG TABLET while breast feeding?
No. MYPLAT 360MG TABLET is generally not recommended for use in breastfeeding
women, small amounts of the medicine can pass into the mother’s milk. Contact
your doctor before taking it.
KD Tripathi. Immunosuppressant Drugs. Essentials of Medical Pharmacology.
Seventh Edition,2013. Page - 883.
Jeffrey J Swigris, Amy L Olson, Aryeh Fischer, David A Lynch, Gregory P
Cosgrove, Stephen K Frankel, Richard T Meehan, Kevin K Brown. Uses of
Mycophenolate mofetil. National Institute of Health. NLM. National Centre for
Biotechnology Information. . 2006. [Accessed on 16th July
2022]
Novartis Pharma GmbH. Electronic Medicines Compendium (EMC); [Revised on July
2021] [Accessed 16th July
2022]
Roche Products Limited. Electronic Medicines Compendium (EMC); [Revised on
January 2022] [Accessed 16th July
2022]
Novartis Pharma GmbH. Electronic Medicines Compendium (EMC); [Revised on July
2021] [Accessed 16th July
2022]
Accord Healthcare B.V. Electronic Medicines Compendium (EMC); [Revised on Oct
2020] [Accessed 16th July
2022]
Roche Pharma AG. European Medical Agency. [Revised in Jan 2021] [Accessed on
16th July
2022]
Biocon. Mycophenolate mofetil. [Accessed on 16th July
2022]
9.Hoffmann-La Roche Limited. Mycophenolate mofetil. [Revised on January 2022]
[Accessed 16th July
2022]
MYPLAT 360MG TABLET contains Mycophenolate mofetil which belongs to the group of
medicines called Immunosuppressants. It is used to manage your body rejecting a
transplanted organ (such as kidney, heart, and liver). It is also given with
other medications such as corticosteroids and ciclosporin.
Your doctor will perform some regular blood tests to monitor any changes in your
body. MYPLAT 360MG TABLET may increases the risk of skin cancer. Limit your
exposure to sunlight and ultraviolet light by covering the exposed areas of skin
as much as possible and by applying sunscreen with a high protective factor.
MYPLAT 360MG TABLET can cause birth defects and miscarriage, hence it is
strictly not recommended for use in pregnant women and breastfeeding women.
MYPLAT 360MG TABLET is not recommended for use in children under 2 years of age.
Contact your doctor before taking.
MYPLAT 360MG TABLET should be used with caution in elderly patients aged 65
years or above. Contact your doctor before taking MYPLAT 360MG TABLET.
The most common side effects of taking MYPLAT 360MG TABLET are nausea, vomiting,
diarrhea, stomach pain, headache, high blood pressure, and low number of white
blood cells. Contact your doctor if the above side effects worsen.
MYPLAT 360MG TABLET belongs to immunosuppressants which reduces the action of
the body's own defense system (the immune system) and manages rejection of the
transplanted organ.
Take MYPLAT 360MG TABLET as advised by your physician. Swallow the medicines
with a glass of water. Do not crush or chew the medicine. Your dosage will vary
depending on the type of transplant you received. Do not stop the medicine
suddenly without the concern of your doctor.
Stop taking MYPLAT 360MG TABLET and contact your doctor immediately if you
experience any of the following side effects:
Diarrhoea:
Drink plenty of water and fruit juice to keep yourself hydrated. Contact your
doctor if the diarrhea did not improve.
Headache:
Rest and relax. Drink plenty of fluids such as water and electrolytes. Apply a
pain-relieving balm on the head if necessary. Do not consume alcohol. Contact
your doctor if the headache did not improve.
Nausea and Vomiting:
Take the medicine, with or just after a meal. Stick to simple meals. Avoid
eating oily or spicy food. Contact your doctor if nausea and vomiting did not
improve.
Dizziness:
Try to rest and relax. Get enough sleep. Avoid driving or operate any machines
while you are feeling dizzy. Do not drink alcohol, as it can aggravate your
dizziness. Contact your doctor if the dizziness did not improve.
Stomach pain:
Try to rest and relax. Eat small meals but take frequently. Keep a heat pad on
your stomach. Contact your doctor if the stomach pain did not improve.
!### PREGNANCY
MYPLAT 360MG TABLET is not recommended for use in pregnant women. Inform your
doctor if you are planning to have a child before taking this medicine. Contact
your doctor before taking MYPLAT 360MG TABLET.
!### BREASTFEEDING
MYPLAT 360MG TABLET is generally not recommended for use in breastfeeding women,
hence small amounts of the medicine can pass into the mother’s milk. Contact
your doctor before taking MYPLAT 360MG TABLET.
!### DRIVING AND USING MACHINES
Do not drive or operate any machines if you feel drowsiness, somnolence,
dizziness, tremor, low blood pressure, numb or confusion after taking MYPLAT
360MG TABLET.
!### KIDNEY
MYPLAT 360MG TABLET should be used with caution in patients with kidney
diseases. Contact your doctor before taking MYPLAT 360MG TABLET.
!### LIVER
MYPLAT 360MG TABLET should be used with caution in patients with liver diseases.
Contact your doctor before taking MYPLAT 360MG TABLET.
!### ALLERGY
Do not take MYPLAT 360MG TABLET if you are allergic (hypersensitive) to
Mycophenolate mofetil, or to some sugars such as lactose, galactose, or glucose
or to other ingredients of this medicine.
!### LUNGS
MYPLAT 360MG TABLET should be used with caution in patients with lung diseases.
Contact your doctor before taking MYPLAT 360MG TABLET.
!### HEART DISEASE
MYPLAT 360MG TABLET should be used with caution in patients with heart diseases.
Contact your doctor before taking MYPLAT 360MG TABLET.
MYPLAT 360MG TABLET is not recommended for use if you:
Before taking MYPLAT 360MG TABLET, inform your doctor if you:
Use in pediatrics:
MYPLAT 360MG TABLET is not recommended for use in children under the age of 2,
because there is limited information on its safety and effectiveness. Contact
your doctor before taking MYPLAT 360MG TABLET.
Use in geriatrics:
MYPLAT 360MG TABLET should be used with caution in elderly patients aged 65
years or above. Contact your doctor before taking MYPLAT 360MG TABLET.
A. Drug-Drug interactions:
Before taking MYPLAT 360MG TABLET, inform your doctor if you are taking any of
the following medicine:
Overdosage:
If you or anyone else accidentally takes too much of MYPLAT 360MG TABLET,
consult your doctor immediately or visit the nearby hospital. Symptoms include
nausea, vomiting, diarrhea, and neutropenia.
| Drug | : | Mycophenolate mofetil |
| Pharmacological Category | : | Immunosuppressants |
| Therapeutic Indication | : | Prevents your body from rejecting a transplanted organ |
| Dosage Forms | : | Tablet, Capsule, Suspension, Oral suspension |
What is MYPLAT 360MG TABLET used for?
MYPLAT 360MG TABLET is used to manage your body from rejecting an organ
transplant (such as kidney, heart, and liver). Contact your doctor before taking
MYPLAT 360MG TABLET.
Can I use MYPLAT 360MG TABLET in pregnancy?
No. MYPLAT 360MG TABLET is strictly not recommended for use in pregnant women
unless considered necessary. Contact your doctor before taking MYPLAT 360MG
TABLET.
Is MYPLAT 360MG TABLET safe?
Yes, MYPLAT 360MG TABLET is safe and well tolerated. Contact your doctor before
taking.
Can I use MYPLAT 360MG TABLET in children?
No, MYPLAT 360MG TABLET is not recommended for use in children under the age of
2, because there is limited information on its safety and effectiveness for
them. Contact your doctor before taking.
How MYPLAT 360MG TABLET work?
MYPLAT 360MG TABLET belongs to immunosuppressants which reduces the action of
the body's own defense system (the immune system) and manages rejection of the
transplanted organ.
Can I use MYPLAT 360MG TABLET while breast feeding?
No. MYPLAT 360MG TABLET is generally not recommended for use in breastfeeding
women, small amounts of the medicine can pass into the mother’s milk. Contact
your doctor before taking it.
KD Tripathi. Immunosuppressant Drugs. Essentials of Medical Pharmacology.
Seventh Edition,2013. Page - 883.
Jeffrey J Swigris, Amy L Olson, Aryeh Fischer, David A Lynch, Gregory P
Cosgrove, Stephen K Frankel, Richard T Meehan, Kevin K Brown. Uses of
Mycophenolate mofetil. National Institute of Health. NLM. National Centre for
Biotechnology Information. . 2006. [Accessed on 16th July
2022]
Novartis Pharma GmbH. Electronic Medicines Compendium (EMC); [Revised on July
2021] [Accessed 16th July
2022]
Roche Products Limited. Electronic Medicines Compendium (EMC); [Revised on
January 2022] [Accessed 16th July
2022]
Novartis Pharma GmbH. Electronic Medicines Compendium (EMC); [Revised on July
2021] [Accessed 16th July
2022]
Accord Healthcare B.V. Electronic Medicines Compendium (EMC); [Revised on Oct
2020] [Accessed 16th July
2022]
Roche Pharma AG. European Medical Agency. [Revised in Jan 2021] [Accessed on
16th July
2022]
Biocon. Mycophenolate mofetil. [Accessed on 16th July
2022]
9.Hoffmann-La Roche Limited. Mycophenolate mofetil. [Revised on January 2022]
[Accessed 16th July
2022]